TARGET.: Gene Therapy for the treatment of diabetic retinopathy (Q2878607): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 40.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 95,819.6 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
40.0 percent
| |||||||||||
| Property / co-financing rate: 40.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 17:50, 4 November 2022
Project Q2878607 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TARGET.: Gene Therapy for the treatment of diabetic retinopathy |
Project Q2878607 in Portugal |
Statements
95,819.6 Euro
0 references
239,549.0 Euro
0 references
40.0 percent
0 references
1 September 2018
0 references
31 August 2021
0 references
UNIVERSIDADE NOVA DE LISBOA
0 references
Q2993197 (Deleted Item)
0 references
38°42'27.90"N, 9°8'11.72"W
0 references
Lisboa
0 references
Identifiers
LISBOA-01-0145-FEDER-028121
0 references